Gilead Sciences Inc (NASDAQ:GILD)

103.53
Delayed Data
As of Feb 27
 -0.66 / -0.63%
Today’s Change
63.50
Today|||52-Week Range
116.83
+9.83%
Year-to-Date

Today’s Trading

Previous close104.19
Today’s open104.28
Day’s range102.71 - 104.34
Volume7,939,977
Average volume (3 months)16,629,862
Market cap$154.2B
Dividend yield--
Data as of 4:14pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+306.08%
Earnings growth (this year)+17.86%
Earnings growth (next 5 years)+14.90%
Revenue growth (last year)+121.81%
P/E ratio14.1
Price/Sales5.76
Price/Book10.06

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-1.25-0.79%
BIIBBiogen-0.51-0.12%
BAXBaxter International...+0.48+0.70%
XONIntrexon Corp-1.86-4.33%
Data as of 4:14pm ET, 02/27/2015

Financials

Next reporting dateApril 21, 2015
EPS forecast (this quarter)$2.26
Annual revenue (last year)$24.9B
Annual profit (last year)$12.1B
Net profit margin48.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account